English | Español
Jamie Barrand | Nov 28, 2015

AMA discussion seeks to improve veterans affairs, stop opioid abuse
Jamie Barrand | Nov 27, 2015

FDA conducts sweep of dietary supplement companies
Jamie Barrand | Nov 26, 2015

Intravenous form of ibuprofen now available in Australia
Jamie Barrand | Nov 26, 2015

American Cancer Society officials call for Congress to take action on tobacco issues
Jamie Barrand | Nov 25, 2015

CDC develops new resources for epilepsy patients, health care providers
Jamie Barrand | Nov 25, 2015

CRS-207 designated as orphan drug for mesothelioma treatment
Jamie Barrand | Nov 25, 2015

Opdivo becomes sole PD-1 inhibitor to increase survival rate of renal cell carcinoma patients
Jamie Barrand | Nov 25, 2015

Marchant introduces Protecting Seniors Access to Proper Care Act

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’